Radiologists play a key role in the cancer care continuum after the initial diagnosis of prostate cancer. This includes regular imaging assessments to monitor growth, and tracking tumor changes to measure the effectiveness of various therapies. For the radiologist evaluating prostate cancer, it is key to first determine the severity of the disease, which determines whether the patient will be monitored over the course of several years, or if immediate treatment is required.


Heart Imaging Technologies announced the release of Precession, a cardiac magnetic resonance solution which allows viewing, analysis and reporting all within a standard web browser.


Multiple studies and products were presented at the 2014 Radiological Society of North America (RSNA) conference in December about emerging technologies in breast imaging, with a focus on how they will affect women who have dense breasts. Most researchers have been comparing the utility of mammography screening versus tomosynthesis.


Barco announced the launch of a new diagnostic display system, Nio 5MP LED. Cleared by the U.S. Food and Drug Administration (FDA) for radiology and mammography and featuring a number of image-enhancing technologies, the 5MP display provides excellent image quality for confident diagnoses.

As healthcare and radiology continue to evolve rapidly, flexibility in the operating room (OR) and imaging lab are key. Consequently, imaging systems need to be versatile as well as able to handle a variety of applications and adapt to any space. These needs have led to the increasing popularity of mobile C-arms, the latest generation of X-ray technology. Today, they are being adapted to handle fluoroscopy, vascular imaging, cardiology and 3-D imaging. 


Recently, the Centers for Medicare and Medicaid Services (CMS) issued a final national coverage determination, effective immediately, that provides for Medicare coverage of screening for lung cancer with low dose computed tomography (LDCT). This screening gives at-risk seniors unprecedented access to care.  


Cancer patients with limited brain metastases (one to four tumors) 50 years old and younger should receive stereotactic radiosurgery (SRS) without whole brain radiation therapy (WBRT), according to a study in the March 15, 2015 issue of the International Journal of Radiation Oncology • Biology • Physics (Red Journal).

Subscribe Now